Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Liver Diseases
- Sponsor
- Methodist Health System
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Portal Pressure Gradient Measurements from Hepatic and Portal Veins
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the efficacy, safety, and adequacy of Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) in patients undergoing EUS-guided liver biopsies.
Detailed Description
Patients undergoing EUS-guided liver biopsy may qualify to participate in this study. The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS- Portal Pressure Gradient Measurement (PPGM) in patients with liver disease referred for EUS-guided liver biopsy.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Portal Pressure Gradient Measurements from Hepatic and Portal Veins
Time Frame: 2 years
A catheter is inserted into the hepatic vein before hepatic venous pressure and portal vein pressure are recorded
Secondary Outcomes
- Correlation between Portal Pressure Gradient Measurements and the presence or absence of portal hypertension(2 years)
- Clinical significance between portal pressure gradient measurement and portal hypertension(2 years)